Home / Conditions / Type 1 Diabetes (page 20)

Type 1 Diabetes

Type 1 Diabetes Treatment and Research: Type 1 diabetes is an autoimmune disorder that destroys pancreatic beta cells. Once called juvenile diabetes, Type 1 is diagnosed most often in children, but can be expressed in adults as well. Incidence is highest among non-hispanic whites, according to the NDEP. Adults with Type 1 make up 5% of all diagnosed diabetes patients.New tools, techniques, treatments, drugs and devices can help you improve outcomes for your patients with Type 1.

New Diagnosing Criteria Possible for Type 1?

By closely examining currently used diagnostic criteria, researchers evaluated whether it might be possible to diagnose type 1 earlier…. Today, diagnostic criteria for type 1 diabetes includes a glucose value ≥ 126 mg/dL and 2-h glucose values ≥ 200 mg/dL. These glucose values were selected because they correspond with observed …

Read More »

Predicting Type 1 Diabetes

It may be possible to predict the development of type 1 diabetes in young children by measuring the presence of autoantibodies in the blood… This comes from new data from The Environmental Determinants of Diabetes in the Young (TEDDY) study. Lead researcher Åke Lernmark, MD, PhD, of Lund University, said …

Read More »

Breastfeeding May Lower Risk of Type 1 Diabetes

A recent study discovers that there may be an association between breastfeeding and lowering risk of type 1 diabetes… The objective of this study was to determine the association of breast feeding duration with the risk of type 1 diabetes in genetically predisposed newborns. In addition, this study looked at …

Read More »

Practical Diabetes Care, 3rd Ed., Excerpt #4: Type 1 Diabetes: Insulin Treatment Part 1 of 2


David Levy, MD, FRCP Introduction Insulin treatment in type 1 diabetes is substitution/replacement hormone treatment, but replacement is much more variable and difficult to achieve than in other hormone deficiencies (e.g. thyroid, adrenal, gonadal hormones) because of the minute-by-minute variation in insulin secretion by the intact pancreas, which cannot yet be …

Read More »

Effects of GIP and GLP-1 on Glucagon Response in Type 1 Diabetes

Glucose-dependent insulinotropic polypeptide and glucagon- like peptide-1 have glucose-dependent effects on glucagon secretion but differ in their effects on type 1 and type 2 diabetes patients… From various studies we know that glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have glucose-dependent effects on glucagon secretion. GIP causes increased glucagon …

Read More »